Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-04-07 4:27 pm Purchase | 2026-03-30 | 13G | ALUMIS INC ALMS | Deep Track Capital LP | 7,362,035 5.980% | 7,362,035 (New Position) | Filing History |
| 2026-03-17 4:16 pm Purchase | 2026-03-09 | 13G | ACLARIS THERAPEUTICS INC ACRS | Deep Track Capital LP | 9,345,000 7.000% | 9,345,000 (New Position) | Filing History |
| 2026-03-11 4:05 pm Purchase | 2026-03-04 | 13G | VERA THERAPEUTICS INC VERA | Deep Track Capital LP | 3,921,362 5.500% | 3,921,362 (New Position) | Filing History |
| 2026-03-04 4:15 pm Purchase | 2026-02-17 | 13G | IMMUNIC INC IMUX | Deep Track Capital LP | 11,454,000 8.690% | 11,454,000 (New Position) | Filing History |
| 2026-02-13 08:53 am Sale | 2025-12-31 | 13G | VIRIDIAN THERAPEUTICS INC VRDN | Deep Track Capital LP | 2,524,833 2.650% | -2,854,164 (-53.06%) | Filing History |
| 2026-02-13 08:52 am Sale | 2025-12-31 | 13G | TERNS PHARMACEUTICALS INC TERN | Deep Track Capital LP | 3,150,000 2.970% | -4,345,000 (-57.97%) | Filing History |
| 2026-02-13 08:51 am Sale | 2025-12-31 | 13G | RAPT THERAPEUTICS INC RAPT | Deep Track Capital LP | 110,448 0.400% | -1,654,052 (-93.74%) | Filing History |
| 2026-02-13 08:50 am Sale | 2025-12-31 | 13G | PALISADE BIO INC COM P PALI | Deep Track Capital LP | 0 0.000% | -10,012,958 (Position Closed) | Filing History |
| 2026-02-13 08:50 am Purchase | 2025-12-31 | 13G | ORUKA THERAPEUTICS INC ORKA | Deep Track Capital LP | 2,161,510 4.470% | 264,730 (+13.96%) | Filing History |
| 2026-02-13 08:49 am Sale | 2025-12-31 | 13G | OLEMA PHARMACEUTICALS INC OLMA | Deep Track Capital LP | 0 0.000% | -3,442,833 (Position Closed) | Filing History |
| 2026-02-13 08:48 am Sale | 2025-12-31 | 13G | JADE BIOSCIENCES, INC. JBIO | Deep Track Capital LP | 0 0.000% | -2,279,892 (Position Closed) | Filing History |
| 2026-02-13 08:47 am Sale | 2025-12-31 | 13G | IMAGENEBIO, INC. IMA | Deep Track Capital LP | 0 0.000% | -878,516 (Position Closed) | Filing History |
| 2026-02-13 08:47 am Sale | 2025-12-31 | 13G | CYBIN INC HELP | Deep Track Capital LP | 2,391,505 4.740% | -680,745 (-22.16%) | Filing History |
| 2026-02-13 08:46 am Sale | 2025-12-31 | 13G | STRUCTURE THERAPEUTICS INC SPO GPCR | Deep Track Capital LP | 12,335,346 5.950% | -312,087 (-2.47%) | Filing History |
| 2026-02-13 08:45 am Sale | 2025-12-31 | 13G | GERON CORP GERN | Deep Track Capital LP | 32,511,271 5.090% | -10,488,729 (-24.39%) | Filing History |
| 2026-02-13 08:44 am Sale | 2025-12-31 | 13G | 89BIO INC ETNB | Deep Track Capital LP | 0 0.000% | -9,356,171 (Position Closed) | Filing History |
| 2026-02-13 08:43 am Purchase | 2025-12-31 | 13G | ENANTA PHARMACEUTICALS INC ENTA | Deep Track Capital LP | 1,956,867 6.780% | 472,354 (+31.82%) | Filing History |
| 2026-02-13 08:42 am Purchase | 2025-12-31 | 13G | DEFINIUM THERAPEUTICS INC DFTX | Deep Track Capital LP | 5,676,540 5.540% | 176,540 (+3.21%) | Filing History |
| 2026-02-13 08:41 am Sale | 2025-12-31 | 13G | AKERO THERAPEUTICS INC AKRO | Deep Track Capital LP | 0 0.000% | -4,400,000 (Position Closed) | Filing History |
| 2026-02-12 4:19 pm Purchase | 2026-02-05 | 13G | BICARA THERAPEUTICS INC BCAX | Deep Track Capital LP | 2,750,000 5.020% | 2,750,000 (New Position) | Filing History |